NCT05764005Completed
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
Source: ClinicalTrials.gov · Last updated 6 Mar 2026
Brief summary (registry, in English)
This is a pilot evaluation of a patient-centered intervention that enables providers to support men on active surveillance to maximize adherence. Conducted in urology practices, this pilot will measure key patient-reported, provider-reported, and implementation outcomes. Successful completion of this work will inform a subsequent multi-center effectiveness-implementation hybrid design trial and ultimately will improve low-risk cancer management by effectively engaging Primary Care Physicians (PCPs) in care delivery.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 39 (actual)
- First submitted
- 28 Feb 2023
- Start date
- 9 Nov 2022
- Primary completion date
- 11 Mar 2024
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Diseases
- Prostate cancer
- NCT number
- NCT05764005
What you commit to
- Study type: Interventional
- Participants enrolled: 39
- From 9 Nov 2022 to the primary completion date, 11 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Patient Inclusion Criteria:
- 55 years old or older
- Men diagnosed with low-risk prostate cancer currently on active surveillance
- Men who identify having a primary care provider
- Access and ability to use the Internet
- Patient Exclusion Criteria:
- Men who are unable to read and/or speak English
- Men with impaired decision-making capacity (such as with a diagnosis of dementia or memory loss)
- PCP Inclusion Criteria:
- Identified by patient on baseline survey as their PCP
- Urologist and Clinic Staff Inclusion Criteria:
- Clinicians or staff at a participating urology clinic, including but not limited to MDs, APPs, and nurses
Age in the registry: 55 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Michigan Rogel Cancer Center Coordinator of this site? Confirm its status | Ann Arbor | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.